TY - CHAP
T1 - Staphylococcal immune evasion proteins
T2 - Structure, function, and host adaptation
AU - Koymans, Kirsten J.
AU - Vrieling, Manouk
AU - Gorham, Ronald D.
AU - van Strijp, Jos A.G.
N1 - Funding Information:
We would like to thank Dr. Carla de Haas, Dr. Daphne Stapels, Dr. Julia Kolata, Dr. Stephen Nutbeam-Tuffs, and Jacques Flores Dourojeanni for useful discussions and critical review of the manuscript. This work was supported by funding from The Dutch Science Foundation NWO (KJK), the ALTANT initiative of the Dutch Ministry of Economic Affairs (MV) H2020, and M.S. Curie (RDG).
Funding Information:
Acknowledgements We would like to thank Dr. Carla de Haas, Dr. Daphne Stapels, Dr. Julia Kolata, Dr. Stephen Nutbeam-Tuffs, and Jacques Flores Dourojeanni for useful discussions and critical review of the manuscript. This work was supported by funding from The Dutch Science Foundation NWO (KJK), the ALTANT initiative of the Dutch Ministry of Economic Affairs (MV) H2020, and M.S. Curie (RDG).
Publisher Copyright:
© Springer International Publishing Switzerland 2015.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Staphylococcus aureus is a successful human and animal pathogen. Its pathogenicity is linked to its ability to secrete a large amount of virulence factors. These secreted proteins interfere with many critical components of the immune system, both innate and adaptive, and hamper proper immune functioning. In recent years, numerous studies have been conducted in order to understand the molecular mechanism underlying the interaction of evasion molecules with the host immune system. Structural studies have fundamentally contributed to our understanding of the mechanisms of action of the individual factors. Furthermore, such studies revealed one of the most striking characteristics of the secreted immune evasion molecules: their conserved structure. Despite high-sequence variability, most immune evasion molecules belong to a small number of structural categories. Another remarkable characteristic is that S. aureus carries most of these virulence factors on mobile genetic elements (MGE) or ex-MGE in its accessory genome. Coevolution of pathogen and host has resulted in immune evasion molecules with a highly host-specific function and prevalence. In this review, we explore how these shared structures and genomic locations relate to function and host specificity. This is discussed in the context of therapeutic options for these immune evasion molecules in infectious as well as in inflammatory diseases.
AB - Staphylococcus aureus is a successful human and animal pathogen. Its pathogenicity is linked to its ability to secrete a large amount of virulence factors. These secreted proteins interfere with many critical components of the immune system, both innate and adaptive, and hamper proper immune functioning. In recent years, numerous studies have been conducted in order to understand the molecular mechanism underlying the interaction of evasion molecules with the host immune system. Structural studies have fundamentally contributed to our understanding of the mechanisms of action of the individual factors. Furthermore, such studies revealed one of the most striking characteristics of the secreted immune evasion molecules: their conserved structure. Despite high-sequence variability, most immune evasion molecules belong to a small number of structural categories. Another remarkable characteristic is that S. aureus carries most of these virulence factors on mobile genetic elements (MGE) or ex-MGE in its accessory genome. Coevolution of pathogen and host has resulted in immune evasion molecules with a highly host-specific function and prevalence. In this review, we explore how these shared structures and genomic locations relate to function and host specificity. This is discussed in the context of therapeutic options for these immune evasion molecules in infectious as well as in inflammatory diseases.
UR - http://www.scopus.com/inward/record.url?scp=85041292752&partnerID=8YFLogxK
U2 - 10.1007/82_2015_5017
DO - 10.1007/82_2015_5017
M3 - Chapter
AN - SCOPUS:85041292752
VL - 409
T3 - Current Topics in Microbiology and Immunology
SP - 441
EP - 489
BT - Current Topics in Microbiology and Immunology
PB - Springer-Verlag
ER -